Illuminating the undetected in biopharma deals, founded on scientific curiosity, transaction discipline, and strategic clarity.
Investors don't need more data. They need better decisions.
Companies don't need more strategy decks. They need transaction outcomes.
Most of what passes for diligence and strategy in biopharma produces more information, not more conviction: another market model, another forecast, another deck with caveats attached. None of it moves a deal forward or tells a board what to actually do.
Blacklight exists to close that gap. This isn't about commercial diligence, a strategy framework, or a data room. It's about the conviction to make an investment decision and the transaction discipline to see it through, on a timeline that matches the deal, not a generic engagement calendar.
We named the firm for that idea. A blacklight reveals what's invisible under ordinary light: the evidence, risk, and opportunity that a standard diligence process or a generic strategy deck never surfaces. Finding it is half the job. Turning it into a decision is the other half, and it's the half most advisors skip.
We move with the speed and ownership of a founder, not the caution of a large institution. Our job is to help you make the call, not hedge around it.
We surface the signal inside noisy markets: the opportunity others haven't yet mapped, stated plainly enough to act on.
Every recommendation is pressure-tested against data and hypothesis, then built to survive a negotiating table, not just an investment committee meeting.
No downstream incentives, no house view to protect: just the evidence, and the decision it points to.
Because we stay small and senior, the partners who pitch an engagement are the same people doing the work: on diligence calls, in negotiation prep, and in the room when it counts. We're not staffing a deal team around you. We're putting our own judgment behind every call, whether the engagement runs three weeks or twelve.
"I am a huge fan of you and your team. You always understand the nuances in each project, work tirelessly to solve the problem, and over deliver."
Chief Commercial Officer"Thank you to the entire team. You delivered an exceptional work product on a very short timeline. Our investment committee was very impressed."
Private Equity Vice President"The corporate strategy project and workshop were exactly what we needed. You pressure tested our perspectives and we now have great alignment across the team."
Biotech Head of BD"You never disappoint. I continually come back to you for all my commercial needs."
Large Pharma Franchise Head"I am a huge fan of you and your team. You always understand the nuances in each project, work tirelessly to solve the problem, and over deliver."
Chief Commercial Officer"Thank you to the entire team. You delivered an exceptional work product on a very short timeline. Our investment committee was very impressed."
Private Equity Vice President"The corporate strategy project and workshop were exactly what we needed. You pressure tested our perspectives and we now have great alignment across the team."
Biotech Head of BD"You never disappoint. I continually come back to you for all my commercial needs."
Large Pharma Franchise HeadTell us about your asset, target, or strategic challenge. We'll follow up within one business day.
Start a Conversation →